| Source | Code | Name | Case count | Share of cases (%) |
|---|---|---|---|---|
| PURCH | PURCH_ATC(L04AB04) | adalimumab; parenteral | 4609 | |
| PURCH | PURCH_ATC(L04AB01) | etanercept; parenteral | 3073 | |
| PURCH | PURCH_ATC(L04AB06) | golimumab; parenteral | 1539 | |
| PURCH | PURCH_ATC(L04AC05) | ustekinumab; parenteral | 829 | |
| PURCH | PURCH_ATC(L04AB05) | certolizumab pegol; parenteral | 828 | |
| PURCH | PURCH_ATC(L04AC10) | secukinumab; parenteral | 756 | |
| PURCH | PURCH_ATC(L04AB02) | infliximab; parenteral | 745 | |
| PURCH | PURCH_ATC(L04AA24) | abatacept; parenteral | 696 | |
| PURCH | PURCH_ATC(L04AC07) | tocilizumab; parenteral | 516 | |
| PURCH | PURCH_ATC(L04AC03) | anakinra; parenteral | 52 |